RxNorm Semantic Concepts Index - 145
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "145".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 14509 | 3-methylfentanyl | Designated preferred name (PT) | NO | |
| RxCUI: 14509 | 3-methylfentanyl | Full form of descriptor (FN) | NO | |
| RxCUI: 1450910 | Cefaclor anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1450910 | Cefaclor anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1450910 | Cefaclor anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1451 | Beta globulin | Designated preferred name (PT) | NO | |
| RxCUI: 1451 | Beta globulin | Full form of descriptor (FN) | NO | |
| RxCUI: 1451217 | Product containing sodium (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1451217 | Product containing sodium (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1451223 | Dihydropyridine derivative calcium channel blocker | Designated preferred name (PT) | NO | |
| RxCUI: 1451223 | Dihydropyridine derivative calcium channel blocker | Full form of descriptor (FN) | NO | |
| RxCUI: 14520 | 3-methylhistidine | Designated preferred name (PT) | NO | |
| RxCUI: 14520 | 3-methylhistidine | Full form of descriptor (FN) | NO | |
| RxCUI: 14520 | 3-methylhistidine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14521 | Methylitaconate delta-isomerase | Designated preferred name (PT) | NO | |
| RxCUI: 14521 | Methylitaconate delta-isomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 14529 | Flavonol 7-O-methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 14529 | Flavonol 7-O-methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 14529 | Flavonol 7-O-methyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1453268 | Technetium (99m-Tc) sulesomab | Designated preferred name (PT) | NO | |
| RxCUI: 1453268 | Technetium (99m-Tc) sulesomab | Full form of descriptor (FN) | NO | |
| RxCUI: 14542 | 3-N-methylspiperone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1454871 | Mercury compound | Designated preferred name (PT) | NO | |
| RxCUI: 1454871 | Mercury compound | Full form of descriptor (FN) | NO | |
| RxCUI: 1454871 | Mercury compound | Designated preferred name (PT) | NO | |
| RxCUI: 1454871 | Mercury compound | Full form of descriptor (FN) | NO | |
| RxCUI: 1455099 | vortioxetine | Full form of descriptor (FN) | YES | |
| RxCUI: 1455099 | vortioxetine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1455099 | vortioxetine | Designated preferred name (PT) | YES | |
| RxCUI: 1455099 | vortioxetine | Full form of descriptor (FN) | YES | |
| RxCUI: 1455099 | vortioxetine | Designated preferred name (PT) | YES | |
| RxCUI: 1455101 | Pefloxacin mesilate dihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1455101 | Pefloxacin mesilate dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1455101 | Pefloxacin mesilate dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1455599 | Alcoholic mixed drink | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1455599 | Alcoholic mixed drink | Designated preferred name (PT) | NO | |
| RxCUI: 1455599 | Alcoholic mixed drink | Full form of descriptor (FN) | NO | |
| RxCUI: 1456746 | Product containing insulin aspart and insulin degludec (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1456746 | Product containing insulin aspart and insulin degludec (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1456913 | Dexrabeprazole | Designated preferred name (PT) | NO | |
| RxCUI: 1456913 | Dexrabeprazole | Full form of descriptor (FN) | NO | |
| RxCUI: 14578 | 3-oxo-5beta-steroid delta^4^-dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 14578 | 3-oxo-5beta-steroid delta^4^-dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 14579 | 3-oxoacyl-[acyl-carrier-protein] reductase | Designated preferred name (PT) | NO | |
| RxCUI: 14579 | 3-oxoacyl-[acyl-carrier-protein] reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 14580 | 3-oxoadipate coenzyme A-transferase | Designated preferred name (PT) | NO | |
| RxCUI: 14580 | 3-oxoadipate coenzyme A-transferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14580 | 3-oxoadipate coenzyme A-transferase | Full form of descriptor (FN) | NO | |
| RxCUI: 14581 | Carboxymethylbutenolide lactonase | Designated preferred name (PT) | NO | |
| RxCUI: 14581 | Carboxymethylbutenolide lactonase | Full form of descriptor (FN) | NO | |
| RxCUI: 14581 | Carboxymethylbutenolide lactonase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 14584 | Etonogestrel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 14584 | Etonogestrel | Designated preferred name (PT) | YES | |
| RxCUI: 14584 | Etonogestrel | Full form of descriptor (FN) | YES | |
| RxCUI: 14584 | Etonogestrel | Designated preferred name (PT) | YES | |
| RxCUI: 14584 | Etonogestrel | Full form of descriptor (FN) | YES | |
| RxCUI: 14585 | 3-oxosteroid delta^1^-dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 14585 | 3-oxosteroid delta^1^-dehydrogenase | Full form of descriptor (FN) | NO |